ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.671,77
-1,64%
S&P 500
5.867,08
-0,09%
Dow Jones
42.342,24
0,00%
Euro vs US Dollar
1,03963
0,31%
Bitcoin
94.127,47
-3,42%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Kanada
  5. TSXV

  6. Arch Biopartners Inc (ARCH) Börsenkurse

Arch Biopartners Inc

Arch Biopartners Inc (ARCH)

Arch Resources Inc
1,72
0,00
(0,00%)
Geschlossen 20 Dezember 10:00PM
Verzögert um 15 Minuten

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
1,72
Gebot
1,72
Fragen
1,87
Volumen
-
0,00 Tagesbereich 0,00
1,31 52-Wochen-Bereich 2,56
Marktkapitalisierung
107,669M
Handelsende
1,72
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
16.155
Ausgegebene Aktien
62.598.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-32,02
Gewinn pro Aktie (EPS)
-0,05
Erlöse
1,98M
Nettogewinn
-3,33M

Über Arch Biopartners Inc

Sektor
Coml Physical, Biologcl Resh
Branche
Advertising Agencies
Website
archbiopartners.com
Hauptsitz
Toronto, Ontario, Can
Gegründet
2010
Arch Biopartners Inc is listed in the Coml Physical, Biologcl Resh sector of the TSX Venture Börse with ticker ARCH. The last closing price for Arch Biopartners was $1,72. Over the last year, Arch Biopartners shares have traded in a share price range of $ 1,31 to $ 2,56.

Arch Biopartners currently has 62.598.000 shares in issue. The market capitalisation of Arch Biopartners is $107,67 million. Arch Biopartners has a price to earnings ratio (PE ratio) of -32.02.

ARCH Neueste Nachrichten

Weitere Nachrichten

Arch Biopartners Announces Dosing of First Patient in Canada in the Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury

TORONTO, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that patient recruitment and dosing have begun...

11 November 2024
GlobeNewswire Inc.

Arch Biopartners Arranges Non-Brokered Private Placement

TORONTO, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced it has arranged a non-brokered private placement...

16 Oktober 2024
GlobeNewswire Inc.

Closes Units for Debt Settlement

TORONTO, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that the Company has closed a transaction that...

03 Oktober 2024
GlobeNewswire Inc.

Units for Debt Settlement

TORONTO, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that the Company has arranged a transaction to...

26 September 2024
GlobeNewswire Inc.

Arch Biopartners Announces Alberta Health Services Approval to Proceed with Phase II Trial for LSALT Peptide Targeting Cardiac Surgery-Associated Acute Kidney Injury (CS-AKI)

TORONTO, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that Alberta Health Services (AHS) has approved...

11 September 2024
GlobeNewswire Inc.

Arch Biopartners’ Cilastatin Drug Candidate to Participate in the PONTIAC Phase II Trial Targeting Acute Kidney Injury Caused by Drug Toxins

Arch is repurposing cilastatin, a dipeptidase-1 inhibitor, as a new treatment for acute kidney injury (AKI)Cilastatin is particularly well suited to prevent AKI caused by drug toxins due to its...

02 August 2024
GlobeNewswire Inc.

Arch Biopartners Closes Non-Brokered Private Placement

TORONTO, July 30, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced it has closed the non-brokered private placement...

30 Juli 2024
GlobeNewswire Inc.

Arch Biopartners Arranges Non-Brokered Private Placement

TORONTO, July 29, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced it has arranged a non-brokered private placement...

29 Juli 2024
GlobeNewswire Inc.

Arch Biopartners Announces GMP Manufacturing of Cilastatin Drug Product

TORONTO, June 27, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced that Dalton Pharma Services (Dalton) has completed the...

27 Juni 2024
GlobeNewswire Inc.

Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury (CS-AKI)

TORONTO, June 18, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that the University of Calgary’s Conjoint Health...

18 Juni 2024
GlobeNewswire Inc.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.15-8.021390374331.871.891.59160961.75246602CS
4-0.24-12.24489795921.9621.59145591.87848488CS
12-0.1-5.494505494511.822.21.59161551.94061513CS
260.010.5847953216371.712.21.36156071.74782381CS
520.2416.21621621621.482.561.31195201.82248399CS
156-2.16-55.67010309283.884.250.97200642.23536188CS
2600.7475.51020408160.985.30.74270431.99153259CS

ARCH - Frequently Asked Questions (FAQ)

What is the current Arch Biopartners share price?
The current share price of Arch Biopartners is $ 1,72
How many Arch Biopartners shares are in issue?
Arch Biopartners has 62.598.000 shares in issue
What is the market cap of Arch Biopartners?
The market capitalisation of Arch Biopartners is CAD 107,67M
What is the 1 year trading range for Arch Biopartners share price?
Arch Biopartners has traded in the range of $ 1,31 to $ 2,56 during the past year
What is the PE ratio of Arch Biopartners?
The price to earnings ratio of Arch Biopartners is -32,02
What is the cash to sales ratio of Arch Biopartners?
The cash to sales ratio of Arch Biopartners is 53,63
What is the reporting currency for Arch Biopartners?
Arch Biopartners reports financial results in CAD
What is the latest annual turnover for Arch Biopartners?
The latest annual turnover of Arch Biopartners is CAD 1,98M
What is the latest annual profit for Arch Biopartners?
The latest annual profit of Arch Biopartners is CAD -3,33M
What is the registered address of Arch Biopartners?
The registered address for Arch Biopartners is 27 ST. CLAIR AVENUE EAST, P.O. BOX 305, TORONTO, ONTARIO, M5V 1M1
What is the Arch Biopartners website address?
The website address for Arch Biopartners is archbiopartners.com
Which industry sector does Arch Biopartners operate in?
Arch Biopartners operates in the ADVERTISING AGENCIES sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
AAAAAuralite Investments Inc
$ 0,265
(0,00%)
0
AAA.PFirst Tidal Acquisition Corp
$ 0,04
(0,00%)
0
AAAlba Minerals Ltd
$ 0,03
(0,00%)
0
A.HArmor Minerals Inc
$ 0,30
(0,00%)
0
AArmor Minerals Inc
$ 0,45
(0,00%)
0
AAAAAuralite Investments Inc
$ 0,265
(0,00%)
0
AAA.PFirst Tidal Acquisition Corp
$ 0,04
(0,00%)
0
AAAlba Minerals Ltd
$ 0,03
(0,00%)
0
A.HArmor Minerals Inc
$ 0,30
(0,00%)
0
AArmor Minerals Inc
$ 0,45
(0,00%)
0
AAAAAuralite Investments Inc
$ 0,265
(0,00%)
0
AAA.PFirst Tidal Acquisition Corp
$ 0,04
(0,00%)
0
AAAlba Minerals Ltd
$ 0,03
(0,00%)
0
A.HArmor Minerals Inc
$ 0,30
(0,00%)
0
AArmor Minerals Inc
$ 0,45
(0,00%)
0

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

TSXV
ARCH
Arch Biopartners
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten